Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03563313 · ClinicalTrials.gov registry record · NA
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT03563313 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 168 participants.
The verdict
NCT03563313, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The objective of the study is to assess efficacy and safety of a closed loop system (t:slim X2 with Control-IQ Technology) in a large randomized controlled trial.
Interventions
- DEVICE t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
- DEVICE Sensor-augmented pump (SAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2019-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03563313
The ClinicalTrials.gov registry entry for NCT03563313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which t:slim X2 with Control-IQ Technology & Dexcom G6 CGM is the first listed.
NCT03563313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03563313 about?
NCT03563313 is a clinical study titled "The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas". The objective of the study is to assess efficacy and safety of a closed loop system (t:slim X2 with Control-IQ Technology) in a large randomized controlled trial.
What is the current status of trial NCT03563313?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2018-06-28. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03563313?
The interventions under investigation include: t:slim X2 with Control-IQ Technology & Dexcom G6 CGM (DEVICE), Sensor-augmented pump (SAP) (DEVICE).
Who is sponsoring clinical trial NCT03563313?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.